Eldecalcitol

艾地骨化醇

Report date: 2023/11/14 13:20:28
NME

Base Information

Drug NameEldecalcitol
Drug Alias Name艾尔骨化醇eldecalcitolum艾迪骨化醇Edirol艾地罗 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsOsteoporosis, PostmenopausalOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaOsteoporosis
Original Approved Country/TerritoryJapan
Original Approved Date2011/01/21
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co LtdNanjing Heron Pharmaceutical Co Ltd
Inactive CompaniesChugai Pharma Science (Beijing) Co LtdShinshu UniversityChugai Pharma Manufacturing Co Ltd Fujieda Plant
Active IndicationsOsteoporosis, PostmenopausalOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeA11C
Related LinksWikipediaDrugBankKEGG